These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 12190331)

  • 21. Drug-grapefruit juice interactions.
    Kane GC; Lipsky JJ
    Mayo Clin Proc; 2000 Sep; 75(9):933-42. PubMed ID: 10994829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation.
    Robles-Piedras AL; Romano-Moreno S; Fuentes-Noriega I; Mancilla-Urrea E; González-López EH; Domínguez-Ramírez A
    Proc West Pharmacol Soc; 2011; 54():30-2. PubMed ID: 22423577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506).
    Qin XL; Bi HC; Wang XD; Li JL; Wang Y; Xue XP; Chen X; Wang CX; Xu le J; Wang YT; Huang M
    Int J Pharm; 2010 Apr; 389(1-2):114-21. PubMed ID: 20097278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug interactions and immunosuppression in organ transplant recipients].
    Vethe NT; Midtvedt K; Asberg A; Amundsen R; Bergan S
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2000-3. PubMed ID: 22016125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics.
    Christians U; Strom T; Zhang YL; Steudel W; Schmitz V; Trump S; Haschke M
    Ther Drug Monit; 2006 Feb; 28(1):39-44. PubMed ID: 16418692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
    Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients.
    Spierings N; Holt DW; MacPhee IA
    Ther Drug Monit; 2013 Jun; 35(3):328-31. PubMed ID: 23666583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.
    Miura M; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Satoh S
    J Clin Pharm Ther; 2011 Apr; 36(2):208-16. PubMed ID: 21366650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation.
    Federico S; Carrano R; Capone D; Gentile A; Palmiero G; Basile V
    Clin Pharmacokinet; 2006; 45(2):169-75. PubMed ID: 16485913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranolazine-tacrolimus interaction.
    Pierce DA; Reeves-Daniel AM
    Ann Pharmacother; 2010 Nov; 44(11):1844-9. PubMed ID: 20876828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.
    Barry M; Gibbons S; Back D; Mulcahy F
    Clin Pharmacokinet; 1997 Mar; 32(3):194-209. PubMed ID: 9084959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus.
    Bruckmueller H; Werk AN; Renders L; Feldkamp T; Tepel M; Borst C; Caliebe A; Kunzendorf U; Cascorbi I
    Ther Drug Monit; 2015 Jun; 37(3):288-95. PubMed ID: 25271728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.
    Vanhove T; Annaert P; Kuypers DR
    Drug Metab Rev; 2016; 48(1):88-112. PubMed ID: 26912097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of tacrolimus.
    Venkataramanan R; Swaminathan A; Prasad T; Jain A; Zuckerman S; Warty V; McMichael J; Lever J; Burckart G; Starzl T
    Clin Pharmacokinet; 1995 Dec; 29(6):404-30. PubMed ID: 8787947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
    Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
    Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir.
    Ouwerkerk-Mahadevan S; Snoeys J; Peeters M; Beumont-Mauviel M; Simion A
    Clin Pharmacokinet; 2016 Feb; 55(2):197-208. PubMed ID: 26353895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.
    Sheikh AM; Wolf DC; Lebovics E; Goldberg R; Horowitz HW
    Transplantation; 1999 Jul; 68(2):307-9. PubMed ID: 10440408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin pharmacokinetics in the elderly.
    Kovarik JM; Koelle EU
    Drugs Aging; 1999 Sep; 15(3):197-205. PubMed ID: 10503812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.